Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2023 - 01 - 25 save search
Sonoma Pharmaceuticals and EMC Pharma Announce Department of Defense DAPA Registration for Microcyn(R) Rx Products
Published: 2023-01-25 (Crawled : 14:20) - biospace.com/
SNOA | $0.1568 -6.72% -7.21% 130K
|
Health Technology
|
| O: 65.83%
H: 34.67%
C: -15.08%
pharmaceuticals pharma defense
First Wave BioPharma Announces Expansion of Adrulipase Intellectual Property Portfolio
Published: 2023-01-25 (Crawled : 12:00) - globenewswire.com
FWBI | $2.82 -2.76% -2.84% 38K
|
Manufacturing
|
| O: 58.37%
H: 7.0%
C: -22.86%
biopharma expansion adrulipase
Millicom (Tigo) confirms discussions on a potential transaction
Published: 2023-01-25 (Crawled : 17:00) - globenewswire.com
TIGO | $19.99 1.94% 1.9% 70K
|
Communications
|
| O: 18.27%
H: 4.39%
C: 4.05%
potential
Vision Energy Engineering Progress Report
Published: 2023-01-25 (Crawled : 13:00) - globenewswire.com
VENG | $0.01 400.0% 2K
|
n/a
|
| O: 17.0%
H: 19.66%
C: 17.95%
energy report
180 Life Sciences Announces Publication of a Review on the Treatments for Early Stage Dupuytren’s Disease
Published: 2023-01-25 (Crawled : 14:00) - globenewswire.com
ATNF | $1.91 0.0% 91K
|
|
| O: 15.77%
H: 45.78%
C: 15.53%
Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
Published: 2023-01-25 (Crawled : 12:00) - globenewswire.com
CDTX | $0.7201 -0.29% -0.29% 270K
|
Health Technology
|
| O: 15.29%
H: 21.5%
C: 19.63%
treatment fda candidiasis approval therapeutics rezafungin candidemia
Inhibikase Therapeutics Announces FDA has Lifted the Full Clinical Hold on IkT-148009 in Parkinson's Disease
Published: 2023-01-25 (Crawled : 13:20) - prnewswire.com
IKT | News | $2.13 0.19% 28K
|
Health Technology
|
| O: 9.85%
H: 15.78%
C: -13.97%
fda disease ikt-148009 lifted parkinson's therapeutics clinical hold
Inhibikase Therapeutics Announces Publication Demonstrating Potential for c-Abl as a Key Therapeutic Target in Parkinson's Disease and Related Disorders
Published: 2023-01-25 (Crawled : 14:00) - prnewswire.com
IKT | News | $2.13 0.19% 28K
|
Health Technology
|
| O: 9.85%
H: 15.78%
C: -13.97%
c-abl disease parkinson's therapeutics potential publication
Inhibikase Therapeutics Announces $10 Million Concurrent Registered Direct Offering and Private Placement Priced at a Premium to Market Under Nasdaq Rules
Published: 2023-01-25 (Crawled : 23:00) - biospace.com/
IKT | News | $2.13 0.19% 28K
|
Health Technology
|
| O: 9.85%
H: 15.78%
C: -13.97%
offering nasdaq therapeutics direct market
Millennium Management Llc Increases Position in Vector Acquisition … – Nasdaq
Published: 2023-01-25 (Crawled : 22:00) - spacfeed.com
LCII 4 | $104.19 0.67% 0.0% 220K
|
Producer Manufacturing
|
| O: -2.12%
H: 2.65%
C: 2.61%
EXPR | $2.52 0.0% 120K
|
Retail Trade
|
| O: 9.71%
H: 1.77%
C: -2.65%
acquisition management nasdaq
Express, Inc. Announces Closing of Transaction to Initiate Strategic … – Business Wire
Published: 2023-01-25 (Crawled : 22:00) - spacfeed.com
LCII 4 | $104.19 0.67% 0.0% 220K
|
Producer Manufacturing
|
| O: -2.12%
H: 2.65%
C: 2.61%
EXPR | $2.52 0.0% 120K
|
Retail Trade
|
| O: 9.71%
H: 1.77%
C: -2.65%
VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023.
Published: 2023-01-25 (Crawled : 18:00) - globenewswire.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition meeting health
Viveon Health Acquisition Pushes Extension Vote Back to Next Week
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition extension health back week
VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of … – GlobeNewswire
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition health
VIVEON HEALTH ACQUISITION CORP. Announces Adjournment of Special Meeting in Connection with Vote to Consummate its Initial Business Combination with Suneva Medical, Inc. Until February 3, 2023. – Yahoo Finance
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition meeting health
Seaport Global II Signs Non-Redemption Agreement for 200K Shares
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
global agreement
Decarbonization Plus IV Shareholders Approve Hammerhead Deal
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
deal plus
Noble Rock Acquisition Sells Sponsor Control
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
acquisition control rock
Decatur School Board discusses ESPLOST funding, projects … – Decaturish.com
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
Highbridge Capital Management Llc Cuts Stake in 7GC & Co … – Nasdaq
Published: 2023-01-25 (Crawled : 18:00) - spacfeed.com
VHAQ | $10.81 0.0% 990
|
|
| O: 9.44%
H: 0.45%
C: -2.25%
management nasdaq
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.